Tennessee · 114 session · senate
SB 421Opioids - As enacted, clarifies that a physician licensed in this state is the only healthcare provider authorized to prescribe a buprenorphine product for a FDA-approved use in recovery or medication-assisted treatment; revises criteria for providers not licensed in this state to prescribe a buprenorphine product for the treatment of opioid use disorder. - Amends TCA Title 33; Title 41; Title 53 and Title 63.
- Status
- In committee
- Latest action
- — Comp. became Pub. Ch. 295
- Primary sponsor
- Reeves
- Opioids
Sponsors
- Reeves · primaryprimary
Effective dates
What law changes on each date. Different sections can land on different dates.